These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9487408)

  • 1. Utility of mass screening programmes in health.
    Kayima JK
    East Afr Med J; 1997 Aug; 74(8):465-6. PubMed ID: 9487408
    [No Abstract]   [Full Text] [Related]  

  • 2. Customizing anticancer strategies to local needs.
    Webb S
    J Natl Cancer Inst; 2009 Jun; 101(12):842-4. PubMed ID: 19509362
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk assessment for prevention of morbidity and mortality: lessons for pressure ulcer prevention.
    Reynolds TM
    J Tissue Viability; 2008 Nov; 17(4):115-20. PubMed ID: 19061825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for disease, cost-effectiveness, and guidelines.
    Meyer DL
    Prim Care; 1995 Dec; 22(4):591-9. PubMed ID: 8668731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effectiveness of prevention: opportunities for public health policy in the Netherlands].
    van den Berg M; de Wit GA; Vijgen SM; Busch MC; Schuit AJ
    Ned Tijdschr Geneeskd; 2008 Jun; 152(23):1329-34. PubMed ID: 18661860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].
    Binquet C; Wallon M; Quantin C; Gadreau M; Peyron F
    Rev Epidemiol Sante Publique; 2002 Oct; 50(5):475-87. PubMed ID: 12471340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of cost-effective early detection programs into the health services of developing countries.
    Sankaranarayanan R
    Cancer; 2000 Aug; 89(3):475-81. PubMed ID: 10931445
    [No Abstract]   [Full Text] [Related]  

  • 9. [General health check ups].
    Engberg M; Lauritzen T
    Ugeskr Laeger; 2002 Jan; 164(2):178-81. PubMed ID: 11831085
    [No Abstract]   [Full Text] [Related]  

  • 10. Depression screening.
    Kessler R
    J Fam Pract; 2003 Jun; 52(6):466; author reply 467. PubMed ID: 12836648
    [No Abstract]   [Full Text] [Related]  

  • 11. Lead poisoning: from screening to primary prevention.
    Gellert GA; Wagner GA; Maxwell RM; Moore D; Foster L
    Pediatrics; 1994 Feb; 93(2):343-4. PubMed ID: 8121754
    [No Abstract]   [Full Text] [Related]  

  • 12. The economic effects of screening for obstructive airway disease: an economic analysis of the DIMCA program.
    van den Boom G; Rutten-van Mölken MP; Folgering H; van Weel C; van Schayck CP
    Prev Med; 2000 Apr; 30(4):302-8. PubMed ID: 10731459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valuing cost in cost utility analysis of screening programme.
    Vanagas G
    J Med Screen; 2004; 11(4):210; author reply 210. PubMed ID: 15563777
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy.
    Ess SM; Szucs TD
    Ital Heart J; 2001 Mar; 2(3):181-8. PubMed ID: 11305529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for colorectal cancer: definitely implement].
    Jansen JB
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1776. PubMed ID: 18754309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who should decide how effective cervical cancer screening will be?
    Austin RM
    J Reprod Med; 1999 Apr; 44(4):317-20. PubMed ID: 10319298
    [No Abstract]   [Full Text] [Related]  

  • 18. [Present status and problems of mass screening--from the viewpoint of public health].
    Miyake K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):515-9. PubMed ID: 3093347
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary health care physicians' views on periodic health evaluation in Saudi Arabia.
    al-Rowais N; Khoja T; al-Farra M; al-Nahedh N
    East Mediterr Health J; 2000; 6(2-3):447-56. PubMed ID: 11556036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The things to come of SHAPE: cost and effectiveness of cardiovascular prevention.
    Diamond GA; Kaul S
    Am J Cardiol; 2007 Apr; 99(7):1013-5. PubMed ID: 17398203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.